Cristcot‘s Phase III ulcerative colitis suppository trial meets endpoints

cafead

Administrator
Staff member
  • cafead   Jan 09, 2025 at 11:22: AM
via Massachusetts gastrointestinal disease firm, Cristcot, has announced results from its Phase III trial examining its hydrocortisone suppository and applicator for ulcerative colitis (UC), finding it to drive remissions and halt rectal bleeding.

article source